HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.

AuthorsDumitru Moldovan, Jonathan A Bernstein, Roman Hakl, Grzegorz Porebski, Kimberly Poarch, William R Lumry, Anurag Relan
JournalThe journal of allergy and clinical immunology. In practice (J Allergy Clin Immunol Pract) 2019 Nov - Dec Vol. 7 Issue 8 Pg. 2938-2940 ISSN: 2213-2201 [Electronic] United States
PMID31170541 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C1 Inhibitor Protein
  • Recombinant Proteins
  • conestat alfa
Topics
  • Adolescent
  • Adult
  • Angioedemas, Hereditary (drug therapy)
  • Complement C1 Inhibitor Protein (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Gestational Age
  • Humans
  • Pregnancy
  • Pregnancy Outcome
  • Recombinant Proteins (administration & dosage, adverse effects, therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: